Leonhardt Ventures LLC Surpasses Historic Milestone with Over 1 Million Patients Treated with Its Inventions and Technology Platforms
HUNTINGTON BEACH, Calif., May 23, 2026
Leonhardt Ventures LLC announced today that technologies, inventions, and derivative product families associated with founder Howard J. Leonhardt and affiliated innovation programs have now contributed to the treatment of more than one million patients worldwide.
The milestone reflects over four decades of innovation spanning cardiovascular devices, regenerative medicine, bioelectric stimulation, intravascular lung, radiation catheters, structural heart technologies, catheter systems, stent grafts, percutaneous heart valves, and biologics therapies.
Bullish
Market Data 
Markets 
